צמיחת הכנסות שנתית ב-12 החודשים האחרונים: Caris Corp (CAI)

לוגו גרפי של Caris Corp (CAI)

Caris Life Sciences, Inc. (CAI) is implementing energy-saving technologies and reducing toxic emissions in its laboratories. The LTM sales volume trend reflects the growing demand from oncology centers for genomic research. This growth is supported by leadership in AI-driven tumor profiling and the development of liquid biopsy. The value of 61.80 reflects the latest metric value, enabling the monitoring of long-term revenue dynamics.

CAI צמיחת מכירות משנה לשנה (TTM) Caris Life Sciences (23.11.2025 - 18.11.2026)

Caris Life Sciences Inc (CAI) - פילוחי מדדים ודוחות פיננסיים

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח כל מדדי החברה:CAI Caris Life Sciences, Inc.
פריט של המותג Caris Life Sciences

This indicator tracks the daily dynamics of annual revenue, allowing investors to differentiate sustainable growth from random fluctuations by analyzing trailing sales changes. This trailing annual revenue change chart from GURU.Markets for Caris Life Sciences, Inc. (CAI) shows that intellectual property protection in the US minimizes volatility, confirming the fundamental strength of the business within the high-tech oncology diagnostics sector.